美股新聞 標題聯播 · 近 24 小時 284 則 · 25 個來源 · 最新 9/20 06:32
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · HRMY近 30 天 4 則 · 第 1 / 1 頁
- Editas (EDIT) Up 6.2% Since Last Earnings Report: Can It Continue?
- Why Is Harmony Biosciences (HRMY) Up 12.1% Since Last Earnings Report?
- Harmony Biosciences Announces Poster Presentations at the 16th European Epilepsy Congress
- Intuit downgraded, SolarEdge upgraded: Wall Street's top analyst calls
- BridgeBio Q2 Earnings Miss, Revenues Beat as Attruby Sales Surge
- ANIP Tops Q2 Earnings, Stock Down on Cortrophin Sales View Cut
- OTLK Up More Than 300% in 3 Months: Here's What You Should Know
- Harmony Biosciences (HRMY) Is Up 9.0% After Q2 Earnings Jump And Pipeline Progress - What's Changed
- Immunocore's Q2 Earnings Miss Estimates, Kimmtrak Aids Y/Y Revenues
- PBYI Q2 Earnings & Sales Beat Estimates, 2026 Guidance Raised
- Insmed Tops Q2 Earnings Estimates, Stock Soars 34% on Brinsupri Uptake
- XENE's Q2 Loss Narrower Than Expected, Sales Nil, Pipeline in Focus
- Perrigo Stock Rises 23% as Q2 Earnings & Sales Beat Estimates
- VTRS Q2 Earnings Beat, Revenues Rise 5% as Greater China Sales Jump
- EDIT Q2 Earnings Beat Estimates, Revenues Rise, Pipeline in Focus
- Harmony Biosciences (HRMY) Soars 10.0%: Is Further Upside Left in the Stock?
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。